TY - JOUR
KW - Diabetes mellitus- Atrial fibrillation
KW - pharmacoepidemiology
KW - SGLT-2 inhibitors
AU - T. Eroglu
AU - R. Coronel
AU - P. Souverein
AD - Amsterdam UMC, Academic Medical Center, University of Amsterdam, Department of Experimental and Clinical Cardiology, Heart Centre, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands.
Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, Copenhagen, Denmark.
Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
AN - 38520149
BT - Eur Heart J Cardiovasc Pharmacother
DO - 10.1093/ehjcvp/pvae022
DP - NLM
ET - 2024/03/23 20:43
LA - eng
N1 - 2055-6845
Eroglu, Talip E
Orcid: 0000-0002-4381-0068
Coronel, Ruben
Orcid: 0000-0001-9433-6119
Souverein, Patrick C
Journal Article
England
Eur Heart J Cardiovasc Pharmacother. 2024 Mar 22:pvae022. doi: 10.1093/ehjcvp/pvae022.
PY - 2024
T2 - Eur Heart J Cardiovasc Pharmacother
TI - Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort study
ER -